Education & Training
Selected Honors & Awards
- Ultrastructural analysis of parvalbumin synapses in human dorsolateral prefrontal cortex.Glausier JR, Roberts RC, Lewis DA.J Comp Neurol. 2017 Jun 15;525(9):2075-2089. doi: 10.1002/cne.24171. Epub 2017 Mar 26.
- Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome.Green IW, Glausier JR.Schizophr Bull. 2016 May;42(3):542-9. doi: 10.1093/schbul/sbv136. Epub 2015 Sep 20. Review.
- Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia.Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA.Schizophr Bull. 2016 Mar;42(2):396-405. doi: 10.1093/schbul/sbv139. Epub 2015 Sep 30.
- Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia.Glausier JR, Kimoto S, Fish KN, Lewis DA.Biol Psychiatry. 2015 Jan 15;77(2):167-76. doi: 10.1016/j.biopsych.2014.05.010. Epub 2014 May 29.
- Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects.Glausier JR, Fish KN, Lewis DA.Mol Psychiatry. 2014 Jan;19(1):30-6. doi: 10.1038/mp.2013.152. Epub 2013 Nov 12. Erratum in: Mol Psychiatry. 2014 Jan;19(1):140.
Now in Molecular Psychiatry: Department Investigators Uncover Molecular Alterations in Obsessive-Compulsive Disorder
Obsessive-compulsive disorder (OCD) is a disabling illness characterized by obsessions that result in compulsive behavior. Underscoring the need for more effective treatments, existing first-line therapies lead to remission in just 10–15% of patients. However, the development of new therapies requires a better understanding of the molecular abnormalities that are present in OCD. A recent study from Pitt Department...
Now in Psychological Medicine: Addressing Challenges to Cognitive Aptitude Assessment in Postmortem Subjects with Schizophrenia
A deep understanding of the neural basis of cognitive impairment in schizophrenia is critical for the development of treatments for this disorder, as cognitive dysfunction can predict clinical outcomes such a relapse frequency and everyday functioning. Achieving this level of understanding is possible by studying post-mortem human brain tissue. However, thus far, scientists have been prevented from doing so due to...
The Department of Psychiatry’s 19th Annual Research Day: A Day to Teach, Learn and Be Inspired
The 19th annual Department of Psychiatry Research Day on June 13, 2019 was our biggest yet! For the 505 faculty, postdoctoral students, residents, graduate students and staff who attended, the morning poster session and afternoon program offered a stimulating day of research and career development that was equal parts enlightenment, inspiration, fun and, at times, surprise. The morning session featured 140 posters...
Department Faculty Selected for 2016 ACNP Travel Awards
Two members of the Department of Psychiatry have been selected for Travel Awards by the American College of Neuropsychopharmacology (ACNP). Jill Glausier, PhD is Assistant Professor of Psychiatry and an active member of the Translational Neuroscience Program at the University of Pittsburgh. Her research interests include investigating excitatory signaling and oxidative phosphorylation alterations in schizophrenia....